Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
for
Chronic Myelogenous Leukemia,
Location: Cincinnati OH, New Brunswick NJ, New York NY, Montreal,
Location: Cincinnati OH, Columbus OH, Ann Arbor MI, Toronto,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT06838676
Phase2, Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
for
Heterozygous Familial Hypercholesterolemia (HeFH)
Location: Cincinnati OH, Morgantown WV, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 6 - 17
Code: NCT07058077
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Bowel Continence Across the Lifespan in People With Spina Bifida
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
for
B-cell Acute Lymphoblastic Leukemia
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 1 - 39
Code: NCT06863259
Phase1, Recruiting
Engaging Mental Health Services for Preschoolers at Risk
for
Mental Health Disorder, Family Navigation,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 18+
Code: NCT07054554
Recruiting
Supraspinal Processing of Sensory Aspects of Pain
for
Migraine in Children, Complex Regional Pain Syndromes,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 10 - 17
Code: NCT05814497
Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
for
Fabry Disease
Location: Cincinnati OH, Pittsburgh PA, Charlotte NC, Fairfax VA,
Sponsor: Amicus Therapeutics
Sex: All
Age: 2 - 11
Code: NCT06904261
Phase3, Recruiting
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
for
Cytomegalovirus (CMV)
Location: Cincinnati OH, Chicago IL, Wilmington DE, Omaha NE,